We are live on ! Find out more
BCDAW

BioCardia, Inc. Warrant
BCDAW

Delisted

BCDAW was delisted on the 2nd of August, 2024.

Back to rankings

3 hedge funds and large institutions have $309K invested in BioCardia, Inc. Warrant in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

390% more capital invested

Capital invested by funds: $63K → $309K (+$246K)

200% more funds holding

Funds holding: 1 → 3 (+2)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
+2
Holders Change %
+200%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
+$478K
2
UBS Group
UBS Group
Switzerland
+$86

Top Sellers

Rank Fund Capital Flow
1
Osaic Holdings
Osaic Holdings
Arizona
-$3.09K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAPTRUST Financial Advisors
1
CAPTRUST Financial Advisors
North Carolina
$276K +$478K +500,000 New
Osaic Holdings
2
Osaic Holdings
Arizona
$33K -$3.09K -3,235 -5%
UBS Group
3
UBS Group
Switzerland
– +$86 +90 New

BCDAW Hedge Fund Activity: Q2 2020 in Review

3 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in BioCardia, Inc. Warrant (BCDAW) for Q2 2020, worth a combined $309K — up 390% from $63K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new BCDAW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was CAPTRUST Financial Advisors, opening a new position worth an estimated $478K. The largest seller was Osaic Holdings, cutting an estimated $3.09K.

  • 3 institutional investors held BioCardia, Inc. Warrant (BCDAW) as of Q2 2020, up from 1 in Q1 2020.
  • Funds reported $309K of BioCardia, Inc. Warrant stock for Q2 2020, up 390% quarter-over-quarter.
  • 2 funds opened new BioCardia, Inc. Warrant positions in Q2 2020 and 0 closed out, a net change of +2 holders.
  • The largest BioCardia, Inc. Warrant buyer in Q2 2020 was CAPTRUST Financial Advisors, an estimated $478K added.
  • The largest BioCardia, Inc. Warrant seller in Q2 2020 was Osaic Holdings, an estimated $3.09K sold.

Based on aggregated 13F filings for Q2 2020.